Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial

Diabetologia, 2021-06, Vol.64 (6), p.1256-1267 [Peer Reviewed Journal]

The Author(s) 2021 ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0012-186X ;ISSN: 1432-0428 ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-021-05407-5 ;PMID: 33665685

Full text available